Anavex Life Sciences Corp (AVXL)

[Talon38]

It is rare that a drug struggles with public acceptance rather than regulatory acceptance which is the case of Biogen's Aduliem. Considering the medical establishments in Europe and the US resistance to Biogen's Alzheimer's drug, we are likely to be in the lead for FDA's New Alzheimer's Drug race with SAVA and ANVS trailing us. Our footing needs to be sure over the next 7 to 8 months in order to break the tape first though..

-----

https://www.investors.com/news/technology/biogen-stock-skids-after-alzheimers-drug-aduhelm-faces-a-setback-in-europe/?src=A00220